Transcatheter Aortic Valve Implantation (TAVI)
Clinical evidence
The Medtronic CoreValve™/Evolut™ platform is supported by a robust body of clinical evidence. Explore the CoreValve™/Evolut™ clinical success.
Stay up to date on the latest clinical evidence from Medtronic. Key summaries demonstrate the efficacy of the CoreValve™/Evolut™ TAVI platform.
The CoreValve™/Evolut™ platform provides reproducible results from clinical trial to the real world.
Explore our STS/ACC TVT Registry™* data that supports the excellent clinical performance seen in our trials.
The purpose of the EXPAND TAVR II Pivotal Trial is to explore the treatment of moderate aortic stenosis (AS) with early aortic valve replacement (AVR) before AS becomes severe. This can lead to preservation of cardiac function, prevention of further deterioration in cardiac function, and prevention of death in some patients.
LinkedIn: Medtronic Cardiac and Vascular
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.